The inflammatory bowel disease (IBD) is incurable, chronic, recrudescent disorders in the
inflamed intestines. Current clinic treatments are challenged by systemic exposure-induced …

Systemic lupus erythematosus (SLE) is a chronic autoimmune disease that was traditionally
thought to be closely related to genetic and environmental risk factors. Although treatment …

Ulcerative colitis is the most prevalent forms of inflammatory bowel diseases and a refractory
autoimmune disease and affects millions of people worldwide. Herein, we develop an oral …

Intestinal immune dysfunction and gut microbiota dysbiosis are critically causative factors in
the pathogenesis of ulcerative colitis (UC); however, the current first-line drugs for UC …

Probiotics are generally used as therapeutic intervention in inflammatory bowel disease.
However, the low survival rate in harsh gastrointestinal environment and limited retention in …

The etiology of inflammatory bowel disease (IBD) is extremely complex and related to an
excessive immune response that results in the pathologically release of reactive oxygen …

Abnormal activation of the intestinal mucosal immune system, resulting from damage to the
intestinal mucosal barrier and extensive invasion by pathogens, contributes to the …

Pharmacologically active natural products have played a significant role in the history of
drug development. They have acted as sources of therapeutic drugs for various diseases …

Ulcerative colitis (UC) is a prevalent idiopathic inflammatory disease which causes such
complications as intestinal perforation, obstruction, and bleeding, and thus deleteriously …

Reactive oxygen species (ROS), acting as essential mediators in the biological system,
highly influence the physiologic and pathologic processes of the human body. The aberrant …